Vaccine developer Moderna could slow Covid-19 trials to add at-risk minorities

The drug developer aims to recruit 30,000 healthy volunteers and said it expected enrollment in the late-stage study, which began in late-July, to be completed in September.

from Hindustan Times - world https://ift.tt/3bxqALs